Search Results - "Hoshida, Yujin"

Refine Results
  1. 1

    Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment by Hoshida, Yujin

    Published in PloS one (23-11-2010)
    “…Gene-expression signature-based disease classification and clinical outcome prediction has not been widely introduced in clinical medicine as initially…”
    Get full text
    Journal Article
  2. 2

    Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine by Fujiwara, Naoto, Friedman, Scott L., Goossens, Nicolas, Hoshida, Yujin

    Published in Journal of hepatology (01-03-2018)
    “…Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies, are at a high risk of developing hepatocellular carcinoma (HCC)…”
    Get full text
    Journal Article
  3. 3

    Hepatitis C virus-induced hepatocellular carcinoma by Goossens, Nicolas, Hoshida, Yujin

    Published in Clinical and molecular hepatology (01-06-2015)
    “…Hepatitis C virus (HCV) is a leading etiology of hepatocellular carcinoma (HCC). The interaction of HCV with its human host is complex and multilayered;…”
    Get full text
    Journal Article Book Review
  4. 4

    MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma by Hectors, Stefanie J., Lewis, Sara, Besa, Cecilia, King, Michael J., Said, Daniela, Putra, Juan, Ward, Stephen, Higashi, Takaaki, Thung, Swan, Yao, Shen, Laface, Ilaria, Schwartz, Myron, Gnjatic, Sacha, Merad, Miriam, Hoshida, Yujin, Taouli, Bachir

    Published in European radiology (01-07-2020)
    “…Objective To assess the value of qualitative and quantitative MRI radiomics features for noninvasive prediction of immuno-oncologic characteristics and…”
    Get full text
    Journal Article
  5. 5

    Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making by Dhanasekaran, Renumathy, Suzuki, Hiroyuki, Lemaitre, Lea, Kubota, Naoto, Hoshida, Yujin

    Published in Hepatology (Baltimore, Md.) (12-06-2023)
    “…Liver cancer, primarily HCC, exhibits highly heterogeneous histological and molecular aberrations across tumors and within individual tumor nodules. Such…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Genome-Wide Methylation Analysis and Epigenetic Unmasking Identify Tumor Suppressor Genes in Hepatocellular Carcinoma by Revill, Kate, Wang, Tim, Lachenmayer, Anja, Kojima, Kensuke, Harrington, Andrew, Li, Jinyu, Hoshida, Yujin, Llovet, Josep M, Powers, Scott

    Published in Gastroenterology (New York, N.Y. 1943) (01-12-2013)
    “…Background & Aims Epigenetic silencing of tumor suppressor genes contributes to the pathogenesis of hepatocellular carcinoma (HCC). To identify clinically…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    STIE: Single-cell level deconvolution, convolution, and clustering in in situ capturing-based spatial transcriptomics by Zhu, Shijia, Kubota, Naoto, Wang, Shidan, Wang, Tao, Xiao, Guanghua, Hoshida, Yujin

    Published in Nature communications (30-08-2024)
    “…In in situ capturing-based spatial transcriptomics, spots of the same size and printed at fixed locations cannot precisely capture the randomly-located single…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals by Baumert, Thomas F, Jühling, Frank, Ono, Atsushi, Hoshida, Yujin

    Published in BMC medicine (14-03-2017)
    “…Hepatitis C virus infection is a major cause of hepatocellular carcinoma worldwide. Interferon has been the major antiviral treatment, yielding viral clearance…”
    Get full text
    Journal Article
  15. 15

    Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma by Hoshida, Yujin, Fuchs, Bryan C, Bardeesy, Nabeel, Baumert, Thomas F, Chung, Raymond T

    Published in Journal of hepatology (01-11-2014)
    “…Summary Hepatitis C virus (HCV) is one of the major aetiologic agents that causes hepatocellular carcinoma (HCC) by generating an inflammatory, fibrogenic, and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice by Villanueva, Augusto, Alsinet, Clara, Yanger, Kilangsungla, Hoshida, Yujin, Zong, Yiwei, Toffanin, Sara, Rodriguez–Carunchio, Leonardo, Solé, Manel, Thung, Swan, Stanger, Ben Z, Llovet, Josep M

    Published in Gastroenterology (New York, N.Y. 1943) (01-12-2012)
    “…Background & Aims The Notch signaling pathway is activated in leukemia and solid tumors (such as lung cancer), but little is known about its role in liver…”
    Get full text
    Journal Article
  18. 18

    Omics‐derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases by Fujiwara, Naoto, Qian, Tongqi, Koneru, Bhuvaneswari, Hoshida, Yujin

    Published in Hepatology research (01-07-2020)
    “…Precise hepatocellular carcinoma (HCC) risk prediction will play increasingly important roles with the contemporary HCC etiologies, that is, non‐alcoholic…”
    Get full text
    Journal Article
  19. 19

    Loss of DNA methylation in zebrafish embryos activates retrotransposons to trigger antiviral signaling by Chernyavskaya, Yelena, Mudbhary, Raksha, Zhang, Chi, Tokarz, Debra, Jacob, Vinitha, Gopinath, Smita, Sun, Xiaochen, Wang, Shuang, Magnani, Elena, Madakashira, Bhavani P, Yoder, Jeffrey A, Hoshida, Yujin, Sadler, Kirsten C

    Published in Development (Cambridge) (15-08-2017)
    “…Complex cytoplasmic nucleotide-sensing mechanisms can recognize foreign DNA based on a lack of methylation and initiate an immune response to clear the…”
    Get full text
    Journal Article
  20. 20